I-123 Biomarker Committee: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{TOCright}} | {{TOCright}} | ||
:Co-chairs: John Dickson, PhD; John Seibyl, MD | :Co-chairs: John Dickson, PhD; John Seibyl, MD | ||
* [http://tinyurl.com/QIBA-SPECT-I-123-Roster Roster | * [http://tinyurl.com/QIBA-SPECT-I-123-Roster Roster] | ||
Latest revision as of 18:47, 21 December 2023
- Co-chairs: John Dickson, PhD; John Seibyl, MD
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases
Recent Meetings/Call Summaries
Profile Development
Reference Materials
- QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018) John Seibyl, MD